C

CNTA

Centessa Pharmaceuticals Plc

13.75

-0.04-0.29%
After Hours: 14.00  +0.25  +1.82%17:36 04/28 EDT

Financial Statements

Statement:

Key indicator

Income Statement

Balance Sheet

Cash Flow

Reporting Period:

Accumulated Report

FY

YoY:
FY: Financial Year Annual Report
Q: Quarter is quarterly reports. Q1, Q2, Q3 and Q4 are reports for a single quarter. Q6 and Q9 are accumulated quarterly reports, respectively contain 6 months' reports and 9 months' report.
Item
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Total Assets

576.80M

360.25M

444.31M

629.63M

11.72M

Total Current Assets

536.41M

315.09M

437.75M

628.77M

11.16M

Total Non Current Assets

40.39M

45.15M

6.56M

861.00K

552.00K

Total Liabilities

175.25M

124.00M

108.14M

138.08M

8.62M

Total Current Liabilities

58.00M

39.38M

38.34M

24.64M

8.62M

Total Non Current Liabilities

117.25M

84.62M

69.80M

113.44M

0

Total Equity

401.55M

236.24M

336.17M

491.55M

3.10M

Total Stockholders Equity

401.55M

236.24M

336.17M

491.55M

3.10M

Minority Interest

--

--

--

--

--

Total Liabilities & Shareholders Equity

576.80M

360.25M

444.31M

629.63M

11.72M

Total Common Shares Outstanding

132.63M

98.77M

94.84M

89.99M

87.42M

Total Preferred Shares Outstanding

--

--

--

--

--